Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among medicare patients with COPD

Chest

Volumn 147, Issue 6, 2015, Pages 1477-1484

  Snider, Julia Thornton ^a   Jena, Anupam B ^b   Linthicum, Mark T ^a   Hegazi, Refaat A ^c   Partridge, Jamie S ^c   LaVallee, Chris ^a   Lakdawalla, Darius N ^d   Wischmeyer, Paul E ^e  

^a PRECISION HEALTH ECONOMICS   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; PROPENSITY SCORE; COMPARATIVE STUDY; MEDICAL RECORD; NUTRITIONAL STATUS; ORAL DRUG ADMINISTRATION; OUTCOME ASSESSMENT; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; FEMALE; HOSPITAL COSTS; HOSPITAL RECORDS; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; MEDICARE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK; UNITED STATES;

EID: 84930904615     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1368     Document Type: Conference Paper

References (52)

1. National Heart Lung and Blood Institute. Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health; 2012.
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2014 update. GOLD website. http://www.goldcopd.org/uploads/users/files/GOLD-Report2014-Feb07.pdf. Published 2014. Accessed August 5, 2014.
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765-773.
4. Hallin R, Gudmundsson G, Suppli Ulrik C, et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101(9):1954-1960.
5. Liu Y, Croft JB, Anderson LA, Wheaton AG, Presley-Cantrell LR, Ford ES. The association of chronic obstructive pulmonary disease, disability, engagement in social activities, and mortality among US adults aged 70 years or older, 1994-2006. Int J Chron Obstruct Pulmon Dis. 2014;9:75-83.
6. Esteban C, Quintana JM, Moraza J, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009;103(8):1201-1208.
7. Hesselink AE, van der Windt DA, Penninx BW, et al. What predicts change in pulmonary function and quality of life in asthma or COPD? J Asthma. 2006;43(7):513-519.
8. Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387-395.
9. Thornton Snider J, Romley JA, Wong KS, Zhang J, Eber M, Goldman DP. The disability burden of COPD. COPD. 2012;9(5):513-521.
10. Rennard S, Decramer M, Calverley PMA, et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J. 2002;20(4):799-805.
11. Robinson AB, Stogsdill JA, Lewis JB, Wood TT, Reynolds PR. RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol. 2012;3:301.
12. Menzin J, Boulanger L, Marton J, et al. The economic burden of chronic obstructive pulmonary disease (COPD) in a US Medicare population. Respir Med. 2008;102(9):1248-1256.
13. Readmissions Reduction Program. Centers for Medicare and Medicaid Services website. http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html. Published 2013. Accessed March 10, 2014.
14. Insights for Improvement: Advancing COPD Care Through Quality Measurement. Washington, DC: National Committee for Quality Assurance; 2009.
15. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance - United States, 1999-2011. Chest. 2013;144(1):284-305.
16. Qaseem A, Wilt TJ, Weinberger SE, et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
17. Vermeeren MA, Schols AM, Wouters EF. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J. 1997;10(10):2264-2269.
18. Sundvall P, Grönberg A, Hulthen L, Slinde F. Energy and nutrient intake in patients with chronic obstructive pulmonary disease hospitalized owing to an acute exacerbation. Scand J Nutr. 2005;49(3):116-121.
19. Creutzberg EC, Wouters EFM, Vanderhoven-Augustin IML, Dentener MA, Schols AMWJ. Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(4 pt 1):1239-1245.
20. Marinari S, Manigrasso MR, De Benedetto F. Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure. Multidiscip Respir Med. 2013;8(1):40.
21. Rogers RM, Donahoe M, Costantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis. 1992;146(6):1511-1517.
22. Schols AM. Nutrition as a metabolic modulator in COPD. Chest. 2013;144(4):1340-1345.
23. Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:31.
24. Hornikx M, Van Remoortel H, Lehouck A, et al. Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir Res. 2012;13:84.
25. Fonseca Wald EL, van den Borst B, Gosker HR, Schols AM. Dietary fibre and fatty acids in chronic obstructive pulmonary disease risk and progression: a systematic review. Respirology. 2014;19(2):176-184.
26. Varraso R, Willett WC, Camargo CA Jr. Prospective study of dietary fiber and risk of chronic obstructive pulmonary disease among US women and men. Am J Epidemiol. 2010;171(7):776-784.
27. Philipson TJ, Snider JT, Lakdawalla DN, Stryckman B, Goldman DP. Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care. 2013;19(2):121-128.
28. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;12:CD000998.
29. Vermeeren MA, Wouters EF, Geraerts-Keeris AJ, Schols AM. Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial. Clin Nutr. 2004;23(5):1184-1192.
30. Norman K, Pirlich M, Smoliner C, et al. Cost-effectiveness of a 3-month intervention with oral nutritional supplements in disease-related malnutrition: a randomised controlled pilot study. Eur J Clin Nutr. 2011;65(6):735-742.
31. Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010;5:341-349.
32. Freijer K, Nuijten MJ, Schols JM. The budget impact of oral nutritional supplements for disease related malnutrition in elderly in the community setting. Front Pharmacol. 2012;3:78.
33. Freijer K, Nuijten MJ. Analysis of the health economic impact of medical nutrition in the Netherlands. Eur J Clin Nutr. 2010;64(10):1229-1234.
34. Myint MW, Wu J, Wong E, et al. Clinical benefits of oral nutritional supplementation for elderly hip fracture patients: a single blind randomised controlled trial. Age Ageing. 2013;42(1):39-45.
35. Gariballa S, Forster S, Walters S, Powers H. A randomized, double-blind, placebocontrolled trial of nutritional supplementation during acute illness. Am J Med. 2006;119(8):693-699.
36. Norman K, Kirchner H, Freudenreich M, Ockenga J, Lochs H, Pirlich M. Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease - a randomized controlled trial. Clin Nutr. 2008;27(1):48-56.
37. Stratton RJ, Hébuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev. 2013;12(4):884-897.
38. Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359-2367.
39. ZuWallack RL, Haggerty MC, Jones P. Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease. Am J Med. 2004;117(suppl 12A):49S-59S.
40. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8 pt 2):757-763.
41. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA. 1994;272(11):859-866.
42. Earle CC, Tsai JS, Gelber RD, Weinstein MC, Neumann PJ, Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol. 2001;19(4):1064-1070.
43. Fang G, Brooks JM, Chrischilles EA. A new method to isolate local-area practice styles in prescription use as the basis for instrumental variables in comparative effectiveness research. Med Care. 2010;48(8):710-717.
44. Kaplan C, Zhang Y. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. J Ment Health Policy Econ. 2012;15(4):171-178.
45. Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc. 1983;78(383):605-610.
46. Chandra RK, Kumari S. Effects of nutrition on the immune system. Nutrition. 1994;10(3):207-210.
47. Efthimiou J, Fleming J, Gomes C, Spiro SG. The effect of supplementary oral nutrition in poorly nourished patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;137(5):1075-1082.
48. van der Hulst RR, von Meyenfeldt MF, van Kreel BK, et al. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition. 1998;14(1):1-6.
49. Cawood AL, Elia M, Stratton RJ. Systematic review and meta-analysis of the effects of high protein oral nutritional supplements. Ageing Res Rev. 2012;11(2):278-296.
50. Ferreira IM, Brooks D, Lacasse Y, Goldstein RS. Nutritional support for individuals with COPD: a meta-analysis. Chest. 2000;117(3):672-678.
51. Ferreira I, Brooks D, Lacasse Y, Goldstein R. Nutritional intervention in COPD: a systematic overview. Chest. 2001;119(2):353-363.
52. National Collaborating Centre for Acute Care (UK). Nutrition Support for Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. London, England: National Collaborating Centre for Acute Care at The Royal College of Surgeons of England; 2006.